Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.92 - $40.2 $33,212 - $1.45 Million
36,100 New
36,100 $36,000
Q2 2022

Jul 21, 2022

BUY
$2.1 - $4.12 $174,300 - $341,960
83,000 New
83,000 $388,000
Q4 2021

Jan 25, 2022

SELL
$3.95 - $7.53 $86,505 - $164,907
-21,900 Closed
0 $0
Q3 2021

Oct 19, 2021

BUY
$6.83 - $13.58 $149,577 - $297,402
21,900 New
21,900 $129,000

Others Institutions Holding CLNN

About Clene Inc.


  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $279M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.